Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPets at home Regulatory News (PETS)

Share Price Information for Pets at home (PETS)

Share Price is delayed by 15 minutes
Get Live Data
171.90    -0.10 (-0.06%)
Bid:
172.40
Ask:
172.60
Spread: 0.20 (0.116%)
Market Cap: £760.28m
PETS Live PriceLast checked at - London Stock Exchange

Intraday Pets at home Share Chart

Q3 FY25 Trading Statement

28 Jan 2025 07:00

RNS Number : 8655U
Pets At Home Group Plc
28 January 2025
 

 

FOR IMMEDIATE RELEASE, 28 JANUARY 2025

Pets at Home Group Plc: Q3 FY25 Trading Statement

for the 12 week period to 2 January 2025

Full year profit guidance maintained

 

Financial Highlights

· Consumer revenue1 was up by 2.3% to £468.0m. With continued strong growth within the Vet Group offsetting a softer performance within our Retail business.

· Total Q3 Group revenue (0.2%) to £361.6m, with Group like-for-like2 (LFL) revenue (1.0%).

·  Vet Group Q3 revenue growth remained strong at 21.3% with LFL of 19.9%. High quality growth continued with Practices seeing double digit revenue growth supported by growth in subscriptions, visits, and average transaction values.

· Retail revenue (2.4%) in Q3 with a (2.8%) LFL. As widely reported across the consumer sector, Q3 saw a more challenging UK consumer backdrop with particularly weak footfall from October. At the same time, our digital performance improved, building momentum through the quarter, with continued strong growth in subscriptions.

 

Current trading and outlook

· Full year underlying PBT guidance is unchanged. We are on track to deliver modest growth in underlying PBT this year as set out at our H1 results. Against a still subdued consumer backdrop, we have maintained a disciplined gross margin performance, supported by strong Christmas seasonal sell through, and effectively managed our costs.

· The transition of our online orders to Stafford DC is underway. We now expect to exit our Northampton DC by the end of the financial year, completing our network optimisation. As a result, we now expect non-underlying costs of £11m (previously £7m) in FY25 due to the phasing of costs associated with our exit from Northampton and will now incur all outstanding costs associated with our exit in FY25 (previously expected to continue into FY26).

· We expect to finish FY25 with a robust balance sheet after investing £55m in CAPEX and returning £85m to shareholders via ordinary dividends and buybacks.

 

Key Performance Indicators

Strategic KPIs

 

FY25 YTD

FY24 YTD

YoY

Number of active Pets Club members3 (m)

8.2m

7.8m7

5%

Average Consumer Value4 (£)

175

177

-1%

% of Consumer Revenue from Subscriptions5 (%)

12.7%

10.0%

27%

Clinical FTE Headcount6 (k)

3.5k

3.3k

7%

 

1.

Consumer revenue includes total revenue across the Group including consumer sales made by Joint Venture vet practices, and therefore differs to the fee income recognised within Vet Group statutory revenue.

2.

Like-for-like revenue comprises total revenue in a financial period compared to revenue achieved in a prior period, for stores, omnichannel operations, grooming salons, and vet practices that have been trading more than 52 weeks prior to both the current and prior period reporting date

3.

Number of active Pets Club members who transacted across the group in the last 365 days prior to the end of the reporting period.

4.

The average spend of active Pets Club members across the group over the last 365 days based on consumer revenue as defined above, rather than statutory revenue.

5.

Subscription revenue includes our Flea & Worm, Easy Repeat, Complete Care and Vac4Life plans and is divided by Group consumer revenue.

6.

Full time equivalent number of all vets and nurses working across the group, based on standard working hours.

7.

Restated from 7.7m reported in Q3 last year

 

Our next scheduled update will be a pre-close update at the end of March.

 

Investor Relations Enquiries

Pets at Home Group Plc:

Andrew Porteous, Director of Investor Relations

+44 (0) 7740 361 849

Aaron Wood, Head of Investor Relations

+44 (0) 7702 083 154

Media Enquiries

Pets at Home Group Plc:

Natalie Cullington, Head of Communications

+44 (0) 7974 594 701

Citigate Dewe Rogerson:

Angharad Couch

+44 (0) 7507 643 004

 

About Pets at Home

Pets at Home Group Plc is the UK's leading pet care business, providing pets and their owners with the very best advice, products and care. Pet products are available online or from over 450 pet care centres, many of which also have vet practices and grooming salons. The Group also operates a leading small animal veterinary business, with over 440 veterinary general practices located both in our pet care centres and in standalone locations. For more information visit: http://petsathomeplc.com/

 

Disclaimer

This trading statement does not constitute an invitation to underwrite, subscribe for, or otherwise acquire or dispose of any Pets at Home Group Plc shares or other securities nor should it form the basis of or be relied on in connection with any contract or commitment whatsoever. It does not constitute a recommendation regarding any securities. Past performance, including the price at which the Company's securities have been bought or sold in the past, is no guide to future performance and persons needing advice should consult an independent financial adviser. Certain statements in this trading statement constitute forward-looking statements. Any statement in this document that is not a statement of historical fact including, without limitation, those regarding the Company's future plans and expectations, operations, financial performance, financial condition and business is a forward-looking statement. Such forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially. These risks and uncertainties include, among other factors, changing economic, financial, business or other market conditions. These and other factors could adversely affect the outcome and financial effects of the plans and events described in this statement. As a result you are cautioned not to place reliance on such forward-looking statements. Nothing in this statement should be construed as a profit forecast.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUBUARVWUAUUR
Date   Source Headline
11th Dec 20193:41 pmRNSHolding(s) in Company
11th Dec 20197:01 amRNSHolding(s) in Company
6th Dec 20193:28 pmRNSHolding(s) in Company
28th Nov 20191:15 pmRNSHolding(s) in Company
26th Nov 20197:00 amRNSHalf-year Report
25th Nov 20193:53 pmRNSHolding(s) in Company
22nd Nov 20199:29 amRNSHolding(s) in Company
11th Nov 20199:23 amRNSHolding(s) in Company
8th Nov 20194:30 pmRNSHolding(s) in Company
7th Nov 20199:43 amRNSHolding(s) in Company
31st Oct 20198:57 amRNSHolding(s) in Company
29th Oct 20195:34 pmRNSHolding(s) in Company
28th Oct 20195:23 pmRNSHolding(s) in Company
24th Oct 20194:57 pmRNSHolding(s) in Company
24th Oct 20197:00 amRNSHolding(s) in Company
20th Sep 20192:15 pmRNSHolding(s) in Company
13th Sep 201912:41 pmRNSHolding(s) in Company
12th Sep 20197:00 amRNSHolding(s) in Company
2nd Aug 20197:00 amRNSTrading Statement
11th Jul 20191:52 pmRNSResult of AGM
14th Jun 20193:20 pmRNSHolding(s) in Company
11th Jun 20197:10 amRNSHolding(s) in Company
11th Jun 20197:00 amRNSAnnual Report & Accounts and AGM Notice
6th Jun 201910:48 amRNSDirector/PDMR Shareholding
6th Jun 201910:47 amRNSDirector/PDMR Shareholding
6th Jun 201910:45 amRNSDirector/PDMR Shareholding
4th Jun 20195:56 pmRNSChange in Director's details
4th Jun 20192:24 pmRNSDirector/PDMR Shareholding
4th Jun 20192:22 pmRNSDirector/PDMR Shareholding
4th Jun 20192:21 pmRNSDirector/PDMR Shareholding
29th May 20191:39 pmRNSHolding(s) in Company
22nd May 20197:00 amRNSFull Year Results
1st May 20194:43 pmRNSHolding(s) in Company
16th Apr 20191:06 pmRNSHolding(s) in Company
15th Apr 20194:55 pmRNSHolding(s) in Company
12th Apr 20193:26 pmRNSHolding(s) in Company
12th Apr 20197:00 amRNSResult of Placing
11th Apr 20194:52 pmRNSProposed Placing
8th Apr 20197:00 amRNSHolding(s) in Company
1st Apr 20194:47 pmRNSHolding(s) in Company
29th Mar 20194:05 pmRNSHolding(s) in Company
22nd Mar 20192:57 pmRNSHolding(s) in Company
20th Mar 20193:29 pmRNSHolding(s) in Company
13th Mar 20197:00 amRNSNotification of Major Holdings
12th Mar 20197:00 amRNSDisclosure to Issuer
7th Feb 20195:15 pmRNSDirector/PDMR Shareholding
22nd Jan 201912:52 pmRNSHolding(s) in Company
22nd Jan 20197:00 amRNSTrading Statement
17th Jan 20197:00 amRNSHolding(s) in Company
10th Jan 20195:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.